RFC
RPTP

Russell Frank Company’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Russell Frank Company’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-151,413
Closed -$2.26M – 3528
2013
Q3 		$2.26M Sell
151,413
-36,736
-20% -$440K ﹤0.01% 1790
2013
Q2 		$1.76M Buy
+188,149
New +$1.27M ﹤0.01% 1830

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Russell Frank Company's RPTP Position: Q4 2013 in Review

Russell Frank Company sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2013, closing a stake of 151,413 shares — an estimated $2.26M sold.

Russell Frank Company first reported a position in RPTP in Q2 2013 and held it in 2 quarters. The position peaked at $2.26M in Q3 2013. 68 funds tracked by Wall St. Rank hold RPTP as of Q4 2013.

  • Russell Frank Company reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2013 after selling out during the quarter.
  • Russell Frank Company sold 151,413 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2013, an estimated $2.26M.
  • Russell Frank Company first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 2 quarters.
  • Russell Frank Company's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $2.26M in Q3 2013.
  • 68 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2013.

Based on Russell Frank Company's 13F filing for Q4 2013, filed 14 Feb 2014.